New Delhi, 21/4: An expert panel of India’s central drug authority has recommended granting emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children in the five to 11 years age group, official sources said on Thursday.
The Subject Expert Committee on Covid-19 of the CDSCO has, however, sought more data from Bharat Biotech to review its emergency use authorisation (EUA) application for use of Covaxin among those aged between two and 11 years, they said.
The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12 to 17 years age group, subject to certain conditions, on March 9 this year.
Comments are closed.